Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2026-03-13 @ 12:59 AM
Study NCT ID:
NCT07001592
Status:
RECRUITING
Last Update Posted:
2025-06-03
First Post:
2025-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
Sponsor:
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RIOT3 - vvDD-hIL2-2-RG-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None